Treatment of Nausea and Emesis During Cancer Chemotherapy

Slides:



Advertisements
Similar presentations
Quality Improvement in Cancer Symptom Assessment and Control: The Provincial Palliative Care Integration Project (PPCIP) Julie E. Gilbert, MSc, PhD, Doris.
Advertisements

Comparison of the Constipation Assessment Scale and Plain Abdominal Radiography in the Assessment of Constipation in Advanced Cancer Patients Kittiphon.
The Relationship Between Depression and Pain Language in Cancer and Chronic Non- Cancer Pain Patients  Thomas C. Sist, DDS, Gerard A. Florio, PhD, Marguerite.
The Treatment of Chronic Cancer Pain in a Cancer Hospital in the Netherlands  Rianne de Wit, MS, Frits van Dam, PhD, Ans Vielvoye-Kerkmeer, PhD, Carlien.
Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 
Assessment of Patient-Reported Clinical Outcome in Pancreatic and Other Hepatobiliary Cancers  Susan Yount, PhD, David Cella, PhD, Kimberly Webster, MA,
Comparison of Tropisetron and Chlorpromazine Combinations in the Control of Nausea and Vomiting in Patients with Advanced Cancer  Kyriaki Mystakidou,
An Exploratory Study to Clarify the Cluster of Symptoms Predictive of Chemotherapy- Related Nausea Using Random Forest Modeling  Alex Molassiotis, RN,
Edmonton, Canada: A Regional Model of Palliative Care Development
Interactive Collaborative Consultation Model in End-Of-Life Care
Allodynia and Pinprick Hypesthesia in Acute Herpes Zoster, and the Development of Postherpetic Neuralgia  Maija Haanpää, MD, Pekka Laippala, PhD, Turo.
Development and Validation of an Instrument for Rapidly Assessing Symptoms: The General Symptom Distress Scale  Terry A. Badger, PhD, PMHCNS-BC, RN, FAAN,
Validation and Psychometric Assessment of a Short Clinical Scale to Measure Chemotherapy-Induced Nausea and Vomiting: The MASCC Antiemesis Tool  Alexander.
The Spanish Version of the Edmonton Symptom Assessment System-Revised (ESAS- r): First Psychometric Analysis Involving Patients With Advanced Cancer  Ana.
Anita L Comley, PhD, RN, AOCN, Elaine DeMeyer, RN, MSN, AOCN 
Fatigue in Gynecological Cancer Patients During and After Anticancer Treatment  Gillian Prue, PhD, James Allen, PhD, Jacqueline Gracey, PhD, Jane Rankin,
Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 
Patient-Reported Pressure Ulcer Pain: A Mixed-Methods Systematic Review  Claudia Gorecki, MSc, S. José Closs, PhD, RGN, Jane Nixon, PhD, RN, Michelle Briggs,
Eduardo Bruera, MD, Raul Sala, MD, Odette Spruyt, MD, J
Geographic Variation in Hospice Use in the United States in 2002
Self-Reported Constipation in Patients With Advanced Cancer: A Preliminary Report  Wadih Rhondali, MD, Linh Nguyen, MD, Lynn Palmer, PhD, Duck-Hee Kang,
Isaac M. Bromberg, MD  Journal of Pain and Symptom Management 
Got Volunteers? Association of Hospice Use of Volunteers With Bereaved Family Members' Overall Rating of the Quality of End-of-Life Care  Eve M. Block,
Reliability and Validity of the Korean Memorial Symptom Assessment Scale—Short Form in Gynecological Cancer Patients  Ju-Hee Nho, PhD, RN, Sung Reul Kim,
Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy  Paul B Jacobsen, PhD, Linda L Garland,
Jean-Pierre Van Buyten, MD  Journal of Pain and Symptom Management 
Transdermal Fentanyl for Chronic Pain in AIDS
Redefining Appropriate Treatment Expectations
Clinical Response to an Outpatient Palliative Care Consultation in Patients With Advanced Cancer and Cancer Pain  Sriram Yennurajalingam, MD, Jung Hun.
The Effects of Family Support, Anxiety, and Post-Treatment Nausea on the Development of Anticipatory Nausea: A Latent Growth Model  Youngmee Kim, PhD,
Manual Acupuncture Reduces Hyperemesis Gravidarum
Characterization of the early pharmacodynamic profile of oral methadone for cancer- related breakthrough pain: a pilot study  Kim Fisher, PhD, Carla Stiles,
Jodi L. Hannan, MD, Steven M. Radwany, MD, Terry Albanese, PhD 
Ecological Momentary Assessment of Fatigue in Patients Receiving Intensive Cancer Therapy  Eileen Danaher Hacker, PhD, APN, AOCN, Carol Estwing Ferrans,
A Pilot Exploration of the Antiemetic Activity of Olanzapine for the Relief of Nausea in Patients with Advanced Cancer and Pain  Steven D. Passik, PhD,
The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer  Jane T. Hickok, MD, MPH, Joseph A. Roscoe,
Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms  Anna-Liisa Kautio, MD, Maija Haanpää, MD, PhD, Tiina Saarto, MD, PhD, Eija.
Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD 
The effect of transdermal fentanyl treatment on serum cortisol concentrations in patients with non-cancer pain  Emine Ozyuvaci, MD, Nergis Yanmaz Alnigenis,
The Pro-Self© Pain Control Program Improves Patients' Knowledge of Cancer Pain Management  Tone Rustøen, RN, PhD, Berit Taraldsen Valeberg, RN, PhD, Eva.
Evaluation of the FICA Tool for Spiritual Assessment
Changing M3G/M6G Ratios and Pharmacodynamics in a Cancer Patient During Long- Term Morphine Treatment  Gertrud Andersen, MD, Lona L Christrup, PhD, Per.
Palliative care units in the netherlands: changes in patients' functional status and symptoms  Michael A. Echteld, PhD, Luc Deliens, PhD, Gerrit van der.
The Assessment of Cancer Pain in North India
The Impact of Symptoms, Coping Capacity, and Social Support on Quality of Life Experience Over Time in Patients with Lung Cancer  Ingela Henoch, RN, PhD,
Cancer Pain Education Journal of Pain and Symptom Management
The Complexity of Symptoms and Problems Experienced in Children with Cancer: A Review of the Literature  Cornelia M. Ruland, RN, PhD, Glenys A. Hamilton,
Richard J Gralla, MD, Frank Griesinger, MD, PhD 
U.S. Hospice Benefits Journal of Pain and Symptom Management
Gertrud Andersen, MD, Lona Christrup, PhD, Per Sjøgren, MD 
The Effectiveness of Acupressure for the Control and Management of Chemotherapy- Related Acute and Delayed Nausea: A Randomized Controlled Trial  Alexander.
Barriers to Cancer Pain Relief
The impact of demographic and disease-specific variables on pain in cancer patients  Tone Rustøen, RN, PhD, Sophie D Fosså, MD, Dr Med Sci, Jon Skarstein,
Evaluating the Quality of Dying and Death
A Scale for Measuring Patient Perceptions of the Quality of End-of-Life Care and Satisfaction with Treatment  Daniel P. Sulmasy, OFM, MD, PhD, Jessica.
Effect of Recombinant Human Erythropoietin on Quality of Life in Cancer Patients Receiving Chemotherapy  Gregoris Iconomou, PhD, Angelos Koutras, MD,
Clinical and Economic Impact of Palliative Care Consultation
A Meta-Analysis of the Relationship Between Response Expectancies and Cancer Treatment-Related Side Effects  Stephanie J. Sohl, PhD, Julie B. Schnur,
A Multicenter Study Comparing Two Numerical Versions of the Edmonton Symptom Assessment System in Palliative Care Patients  Sharon M. Watanabe, MD, Cheryl.
Physical Function in Patients with Cancer
Gerd Inger Ringdal, PhD, Marit S Jordhøy, MD, Stein Kaasa, PhD 
Longitudinal Documentation of Cancer Pain Management Outcomes
Multidimensional independent predictors of cancer-related fatigue
Assessment of Pain Experiences after Elective Surgery
The Complexity of Symptoms and Problems Experienced in Children with Cancer: A Review of the Literature  Cornelia M. Ruland, RN, PhD, Glenys A. Hamilton,
The Association of Depression and Pain with Health-Related Quality of Life, Disability, and Health Care Use in Cancer Patients  Kurt Kroenke, MD, Dale.
A Multicenter Study Comparing Two Numerical Versions of the Edmonton Symptom Assessment System in Palliative Care Patients  Sharon M. Watanabe, MD, Cheryl.
Cancer Symptom Clusters: A Validation Study
Fatigue in Gynecological Cancer Patients During and After Anticancer Treatment  Gillian Prue, PhD, James Allen, PhD, Jacqueline Gracey, PhD, Jane Rankin,
Nausea and Vomiting Remain a Significant Clinical Problem
Presentation transcript:

Treatment of Nausea and Emesis During Cancer Chemotherapy Sussanne Börjeson, RN, PhD, Timo J Hursti, DrMedSc, Carol Tishelman, RN, DrMedSc, Curt Peterson, MD, PhD, Gunnar Steineck, MD, PhD  Journal of Pain and Symptom Management  Volume 24, Issue 3, Pages 345-358 (September 2002) DOI: 10.1016/S0885-3924(02)00543-2

Figure 1 a. Proportions (%) of patients in each group free from acute nausea during cycles 1–4. b. Proportions (%) of patients in each group free from delayed nausea during cycles 1–4. Journal of Pain and Symptom Management 2002 24, 345-358DOI: (10.1016/S0885-3924(02)00543-2)

Figure 1 a. Proportions (%) of patients in each group free from acute nausea during cycles 1–4. b. Proportions (%) of patients in each group free from delayed nausea during cycles 1–4. Journal of Pain and Symptom Management 2002 24, 345-358DOI: (10.1016/S0885-3924(02)00543-2)

Figure 2 Mean change from baseline VAS rating of well-being to the ratings in cycles 1–4. A positive change means improved ratings of well-being compared to the baseline assessment. Journal of Pain and Symptom Management 2002 24, 345-358DOI: (10.1016/S0885-3924(02)00543-2)